Galapagos NV
GLPG
#4563
Rank
S$2.73 B
Marketcap
S$40.94
Share price
-0.57%
Change (1 day)
13.48%
Change (1 year)

Galapagos NV (GLPG) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : S$1.61 Billion

According to Galapagos NV's latest financial reports the company's total liabilities are S$1.61 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Galapagos NV - Total liabilities on balance sheet (from 2008 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31S$1.75 B-23.16%
2023-12-31S$2.28 B-28.2%
2022-12-31S$3.17 B-18.65%
2021-12-31S$3.90 B-21.27%
2020-12-31S$4.95 B2.83%
2019-12-31S$4.82 B1269.83%
2018-12-31S$0.35 B-20.03%
2017-12-31S$0.44 B-10.93%
2016-12-31S$0.49 B312.23%
2015-12-31S$0.11 B15.97%
2014-12-31S$0.10 B-50.86%
2013-12-31S$0.21 B11.27%
2012-12-31S$0.18 B163.41%
2011-12-31S$71.77 M-7.83%
2010-12-31S$77.87 M11.16%
2009-12-31S$70.06 M1.57%
2008-12-31S$68.97 M-34.47%
2007-12-31S$0.10 B-10.46%
2006-12-31S$0.11 B191.8%
2005-12-31S$40.28 M247.04%
2004-12-31S$11.6 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
AstraZeneca
AZN
S$88.74 B 5,379.63%๐Ÿ‡ฌ๐Ÿ‡ง UK
Johnson & Johnson
JNJ
S$147.13 B 8,984.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$85.56 B 5,182.97%๐Ÿ‡ซ๐Ÿ‡ท France
AbbVie
ABBV
S$176.88 B 10,821.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Fortress Biotech
FBIO
S$0.15 B-90.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$42.65 B 2,533.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$42.24 B 2,508.56%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
GlaxoSmithKline
GSK
S$79.41 B 4,803.50%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
S$100.61 B 6,112.06%๐Ÿ‡บ๐Ÿ‡ธ USA